CELTRO
CELTRO develops battery-free, energy-harvesting implantable devices for cardiac applications. The technology leverages advanced semiconductor design and nanotechnology to power implants using the body's own energy.
- CEO / Founder
- Gerd Teepe
- Team Size
- 10-50
- Stage
- Seed
- Total Funding
- €3M
- Latest Round
- Seed
- Key Investors
- Free State of Saxony
Technology & Products
Key Products
["NanoPower-BioChip technology for energy harvesting","Battery-free pacemakers","Loop recorders","Biosensors"]
Technological Advantage
Operates efficiently in the nanowatt range using FinFET and FDSOI semiconductor technologies, supported by a strong IP portfolio including multiple European and PCT filings.
Differentiation
Value Proposition
Provides self-powered cardiac implants that eliminate the risks associated with battery replacements, reduce repetitive surgeries, and lower long-term healthcare costs.
How They Differentiate
Innovative battery-free approach reduces surgical risks and maintenance challenges compared to traditional pacemakers.
Market & Competition
Target Customers
Hospitals, cardiologists, and healthcare providers treating patients needing cardiac implants
Industry Verticals
["Medical devices","Cardiovascular healthcare","Implantable electronics"]
Competitors
Medtronic; Traditional battery-powered pacemaker manufacturers; Emerging energy-harvesting device research groups (notably in Asia)
Growth & Milestones
Growth Metrics
Key milestones achieved in prototype development, successful IP filings, and early clinical interest.
Major Milestones
["Development of a prototype NanoPower-BioChip","Securing seed funding and regional investor support","Establishing key collaborations with Nano Dimension and leading cardiologists","Filing multiple patents to solidify technological advantage"]
Notable Customers
Collaborative case studies with Nano Dimension